Jun, Ji Hae <br/><br/>
Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.  [electronic resource] 

 -  European journal of pharmacology  Dec 2014 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2014.09.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Animals<br/>Apoptosis<br/>Cardiotonic Agents--administration & dosage<br/>Caspase 3--metabolism<br/>Cell Line<br/>Erythropoietin--administration & dosage<br/>GATA4 Transcription Factor--metabolism<br/>Hyperglycemia--complications<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Myocardial Reperfusion Injury--metabolism<br/>Myocytes, Cardiac--drug effects<br/>Phosphorylation<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Ubiquitination